BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20171716)

  • 1. Tissue factor microparticles and haemophilia.
    Gross PL; Vaezzadeh N
    Thromb Res; 2010 Apr; 125 Suppl 1():S67-9. PubMed ID: 20171716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of procoagulant microparticles and properties.
    Freyssinet JM; Toti F
    Thromb Res; 2010 Apr; 125 Suppl 1():S46-8. PubMed ID: 20153515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation.
    Lacroix R; Dignat-George F
    Thromb Res; 2012 May; 129 Suppl 2():S27-9. PubMed ID: 22424856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylserine positive microparticles improve hemostasis in in-vitro hemophilia A plasma models.
    Zong Y; Pruner I; Antovic A; Taxiarchis A; Vila ZP; Soutari N; Mobarrez F; Chaireti R; Widengren J; Piguet J; Antovic JP
    Sci Rep; 2020 May; 10(1):7871. PubMed ID: 32398812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development.
    Gross PL; Furie BC; Merrill-Skoloff G; Chou J; Furie B
    J Leukoc Biol; 2005 Dec; 78(6):1318-26. PubMed ID: 16204641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.
    Hrachovinová I; Cambien B; Hafezi-Moghadam A; Kappelmayer J; Camphausen RT; Widom A; Xia L; Kazazian HH; Schaub RG; McEver RP; Wagner DD
    Nat Med; 2003 Aug; 9(8):1020-5. PubMed ID: 12858167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dying for attention: microparticles and angiogenesis.
    Boulanger CM; Tedgui A
    Cardiovasc Res; 2005 Jul; 67(1):1-3. PubMed ID: 15904903
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-derived microparticles: a new challenge in neuroscience.
    Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
    J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans.
    Lubsczyk B; Kollars M; Hron G; Kyrle PA; Weltermann A; Gartner V
    Eur J Clin Invest; 2010 Jun; 40(6):477-82. PubMed ID: 20456486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation.
    Furie B; Furie BC
    Trends Mol Med; 2004 Apr; 10(4):171-8. PubMed ID: 15059608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tissue factor positive microparticles.
    Key NS
    Thromb Res; 2010 Apr; 125 Suppl 1(Suppl 1):S42-5. PubMed ID: 20189224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation.
    McEver RP
    Thromb Haemost; 2001 Sep; 86(3):746-56. PubMed ID: 11583304
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction.
    Del Turco S; Basta G; Lazzerini G; Evangelista M; Rainaldi G; Tanganelli P; Christensen JH; Schmidt EB; De Caterina R
    Haematologica; 2008 Jun; 93(6):892-9. PubMed ID: 18469350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detached endothelial cells and microparticles as sources of tissue factor activity.
    Kushak RI; Nestoridi E; Lambert J; Selig MK; Ingelfinger JR; Grabowski EF
    Thromb Res; 2005; 116(5):409-19. PubMed ID: 16122554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of hemostasis by cancer.
    Monroe DM; Hoffman M
    Cancer Treat Res; 2009; 148():3-15. PubMed ID: 19377915
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelets: physiology and biochemistry.
    Jurk K; Kehrel BE
    Semin Thromb Hemost; 2005; 31(4):381-92. PubMed ID: 16149014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection.
    Morel O; Ohlmann P; Epailly E; Bakouboula B; Zobairi F; Jesel L; Meyer N; Chenard MP; Freyssinet JM; Bareiss P; Mazzucotelli JP; Toti F
    J Heart Lung Transplant; 2008 Jan; 27(1):38-45. PubMed ID: 18187085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis and cancer: tumor cells induce the expression of tissue factor-like procoagulant activity on endothelial cells.
    Maiolo A; Tua A; Grignani G
    Haematologica; 2002 Jun; 87(6):624-8. PubMed ID: 12031919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.